Unit 2 sem 6 gen
Unit 2 sem 6 gen
In this project, two different and significant methods are typically used.
1.Expressed sequence tags wherein the genes were differentiated into the ones forming a
part of the genome and the others which expressed RNAs.
2.Sequence Annotation wherein the entire genome was first sequenced and the functional
tags were assigned later.
Epigenetic modifications
Epigenetics is the study of heritable changes in gene expression (active versus inactive genes)
that do not involve changes to the underlying DNA sequence — a change in phenotype
without a change in genotype — which in turn affects how cells read the genes
Dna methylation
DNA methylation is a process by which methyl groups are added to the DNA molecule.
It is an epigenetic mechanism that occurs by the addition of a methyl (-CH3) group to
DNA, thereby often modifying the function of the genes and affecting gene
expression.
The most widely characterized DNA methylation process is the covalent addition of
the methyl group at the 5-carbon of the cytosine ring resulting in 5-methylcytosine (5-
mC), also informally known as the “fifth base” of DNA.
These methyl groups project into the major groove of DNA and inhibit transcription.
In human DNA, 5-methylcytosine is found in approximately 1.5% of genomic DNA.
It is typically removed during zygote formation and then re-established in the embryo
at approximately the time of implantation.
It is the basis of chromatin structure and usually is found in a CpG dinucleotide
context.
Research has shown that methylation plays a crucial role in the regulation of gene
expression and that these modifications tend to occur at specific locations within the
genomes of different species.
It has been demonstrated as a vital contributor to a wide range of cellular processes,
and aberrant methylation patterns have been linked to several human diseases.
Histone Modification
Histone proteins are the main components of chromatin, acting as spools around
which DNA wlnds. Post-translational modifications of histones, such as methylation,
acetylation, phosphorylation. ubiquitination. and sumoylation, play a critical role in
regulating chromatin structure and gene expression.
Types of Modifications:
. Acetylation: Addition of acetyl groups (by histone acetyltransferases, HATs)
typically occurs on lysine residues of histone tails, reducing the positive charge of
histones and decreasing their interaction with negatively charged DNA. This usually
results in a more relaxed chromatin structure, promoting gene transcription. Histone
deacetylases (HDACs) remove these groups. leading to chromatin condensation and
gene repression.
Genomic Imprinting
Proteome analysis:
Mass Spectrometry(MS): The most common tool for proteomics, It identifies protelns
by measuring the mass-to-charge ratio of their peptide fragments. Technlques like
tandem MS (MS/MS) enhance accuracy by further fragmenting selected peptides for
more detailed analysis.
2.Post-translatlonal Modifications(PTMs):
3.Protein Interactions:
Proximity labeling methods like BioID and APEX can also map interaction networks
within cells.
Protein array
Each protein spot on the array represents a different protein, and multiple replicates of
each protein are typically included on the array to ensure data reproducibility
A variety of materials can be immobilize on the protein chip based on the specific
requirements. These include:
1.Analytical microarrays
2.Functional
3.Reverse phase
Pharmacogenomics is the study of how genes affect a person's response to drugs. This
field combines pharmacology (the science of drugs) and genomics (the study of genes
and their functions) to develop effective, safe medications and doses tailored to a
person's genetic makeup. The goal of pharmacogenomics is to optimize drug therapy,
with respect to the patients' genotype, to ensure maximum efficacy with minimal
adverse effects.
Single Nucleotide Polymorphisms tSNPs) are the most common type of genetic
variation among people. Each SNP represents a difference in a single nucleotide, the
building blocks of DNA. These variations can affect how individuals respond to drugs
by altering the function of enzymes that metabolize medications, receptors that drugs
target, and transporters that move drugs within the body.
G6PD is an enzyme that plays a crucial role in the pentose phosphate pathway, a
metabolic pathway that protects red blood cells (RBCs) from oxidative damage by
producing NADPH. NADPH is essential for maintaining the level of glutathione, a
powerful antioxidant, which helps protect RBCs from oxidative stress.
G6PD Deficiency:
G6PD deficiency is a genetic disorder that results from mutations in the G6PD gene.
This condition is X-linked and more common in males. People with G6PD deficiency
have lower levels of the G6PD enzyme, making their RBCs more susceptible to
oxidative damage.
SNPs in the G6PD gene can lead to varying degrees of enzyme deficiency. This
variation significantly impacts drug response, especially to drugs known to cause
oxidative stress, such as certain antimalarials (e.g., primaquine), sulfonamides, and
some antibiotics.